Anuroj K, Pathmanand C, Sueblinvong V, Thisyakorn C, Chotivitayatarakorn P
Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Southeast Asian J Trop Med Public Health. 1997 Jun;28(2):375-9.
Nine pediatric symptomatic patients infected with human immunodeficiency virus with elevated pulmonary arterial pressure (MPA pressure) and ejection fraction (EF); and with fractional shortening, (FS) mean velocity of circumferential fiber shortening (MVCfc) and left ventricular peak systolic wall stress (PS) were prospectively evaluated using 2-dimensional and M-mode serial echocardiography and Doppler cardiography after administration of an ACE inhibitor (Inhibace 0.025 mg/kg/D orally) for 12 weeks. The MPA pressure was not decreased, however the MVCfc and PS improved significantly (p < 0.05). Further, long term evaluation is required to determine its effect in preventing dilated cardiomyopathy and elevated mean pulmonary pressure.
对9名感染人类免疫缺陷病毒的儿科症状性患者进行了前瞻性评估,这些患者肺动脉压(MPA压力)和射血分数(EF)升高;伴有缩短分数(FS)、圆周纤维缩短平均速度(MVCfc)和左心室收缩期峰值壁应力(PS),在口服血管紧张素转换酶抑制剂(依那普利0.025 mg/kg/天)12周后,使用二维和M型系列超声心动图以及多普勒心动图进行评估。MPA压力未降低,但MVCfc和PS有显著改善(p<0.05)。此外,需要进行长期评估以确定其在预防扩张型心肌病和平均肺动脉压升高方面的作用。